AdaptHealth Corp. (AHCO) is a Medical - Devices company in the Healthcare sector, currently trading at $12.77. It has a SharesGrow Score of 42/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of AHCO = $83.36 (+552.8% from the current price, the stock appears undervalued). Analyst consensus target is AHCO = $13 (-2.1% upside).
Valuation: AHCO trades at a trailing Price-to-Earnings (P/E) of -22.6 (S&P 500 average ~25).
Financials: revenue is $3.2B, +3%/yr average growth. Net income is $71M (loss), growing at -381.5%/yr. Net profit margin is -2.2% (negative). Gross margin is 17.5% (+3.4 pp trend).
Balance sheet: total debt is $1.9B against $1.5B equity (Debt-to-Equity (D/E) ratio 1.25, moderate). Current ratio is 1.02 (adequate). Debt-to-assets is 44.1%. Total assets: $4.3B.
Analyst outlook: 9 / 12 analysts rate AHCO as buy (75%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 64/100 (Pass), Growth 30/100 (Fail), Past 50/100 (Partial), Health 33/100 (Fail), Moat 46/100 (Partial), Future 59/100 (Partial), Income 10/100 (Fail).
